The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Nudnov N.V.

National Medical Radiology Research Center;
Peoples’ Friendship University of Russia named after Patrice Lumumba;
Russian Medical Academy of Continuous Professional Education

Aksenova S.P.

National Medical Radiology Research Center

Ivashina S.V.

National Medical Radiology Research Center

Pelvic recurrences of ovarian cancer: sonographic visualization and magnetic resonance imaging

Authors:

Nudnov N.V., Aksenova S.P., Ivashina S.V.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2024;13(5): 31‑39

Read: 1128 times


To cite this article:

Nudnov NV, Aksenova SP, Ivashina SV. Pelvic recurrences of ovarian cancer: sonographic visualization and magnetic resonance imaging. P.A. Herzen Journal of Oncology. 2024;13(5):31‑39. (In Russ.)
https://doi.org/10.17116/onkolog20241305131

Recommended articles:

References:

  1. Kaprin AD, Starinskii VV, Shakhzadova AO, eds. The state of oncological care for the population of Russia in 2020. M.: MNIOI named after P.A. Herzen — branch of the Federal State Budgetary Institution «NMITs Radiology» of the Ministry of Health of Russia; 2021;239. (In Russ.).
  2. Manganaro L, Gigli S, Antonelli A, Saldari M, Tomao F, Marchetti C, Anastasi E, Laghi A. Imaging strategy in recurrent ovarian cancer: a practical review. Abdom Radiol (NY). 2019;44(3):1091-1102. https://doi.org/10.1007/s00261-018-1677-y
  3. Hennessy BT, Coleman RL, Markman M. Ovarian cancer. Lancet. 2009;374(9698):1371-1382. https://doi.org/10.1016/S0140-6736(09)61338-6
  4. Bulanova IM, Bulanova TV, Burenchev DV. Ultrasound and magnetic resonance diagnostics of relapses and metastases of ovarian cancer. Bulletin of Roentgenology and Radiology. 2006;(1):53-58. (In Russ.).
  5. Ozerskaya IA, Chekalova MA, Ivanov VA, Kazaryan GG. Ultrasound signs of ovarian tumors according to a standardized protocol. Medical Imaging. 2023;27(2):110-124. (In Russ.). https://doi.org/10.24835/1607-0763-1144
  6. Ivashina SV, Antonova IB, Babaeva NA, Aleshikova OI, Ashrafyan LA. The role of modern ultrasound methods in the early diagnosis of recurrence of ovarian cancer. Difficult Patient. 2018;16(8-9):12-15. (In Russ.). https://doi.org/10.24411/2074-1995-2018-10002
  7. Antonova IB, Ivashina SV, Ashrafyan LA, Babaeva NA, Aleshikova OI. Criteria for the choice of diagnostic methods in patients with recurrent ovarian cancer. Bulletin of the Russian Scientific Center of Roentgenoradiology of the Ministry of Healthcare of the Russian Federation. 2018;18(4):16-28. (In Russ.). Available at: https://vestnik.rncrr.ru/vestnikrncrr/vestnik/v18/v18.htm
  8. Ivashina SV, Antonova IB, Aleshikova OI, Ashrafyan LA. Modern ultrasound diagnostics in the early detection of ovarian cancer relapses. Obstetrics and Gynecology. News. Opinions. Education. 2019;7(1):39-45. (In Russ.).
  9. Huang Q, Zeng Z. A review on real-time 3D ultrasound imaging technology. Biomed Res Int. 2017;2017:6027029. https://doi.org/10.1155/2017/6027029
  10. Singh K, Malhotra N. Step by step: 3D/4D ultrasound in obstetrics, gynecology and infertility. 2nd ed. Jaupee Brothers Medical Pub; 2013;133. 
  11. Sala E, Kataoka MY, Priest AN, Gill AB, McLean MA, Joubert I, Graves MJ, Crawford RA, Jimenez-Linan M, Earl HM, et al. Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects. Radiology. 2012;263(1):149-159.  https://doi.org/10.1148/radiol.11110175
  12. Low RN, Duggan B, Barone RM, Saleh F, Song SY. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology. 2005;235(3):918-926.  https://doi.org/10.1148/radiol.2353040447
  13. Gu P, Pan LL, Wu SQ, Sun L, Huang G. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2009;71(1):164-174.  https://doi.org/10.1016/j.ejrad.2008.02.019
  14. Forstner R, Thomassin-Naggara I, Cunha TM, Kinkel K, Masselli G, Kubik-Huch R, Spencer JA, Rockall A. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol. 2017;27(6):2248-2257. https://doi.org/10.1007/s00330-016-4600-3
  15. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386. https://doi.org/10.1002/ijc.29210
  16. Amate P, Huchon C, Dessapt AL, Bensaid C, Medioni J, Le Frère Belda MA, Bats AS, Lécuru FR. Ovarian cancer: sites of recurrence. Int J Gynecol Cancer. 2013;23(9):1590-1596. https://doi.org/10.1097/IGC.0000000000000007
  17. Dao MD, Alwan LM, Gray HJ, Tamimi HK, Goff BA, Liao JB. Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers. Gynecol Oncol. 2013;130(2):295-299.  https://doi.org/10.1016/j.ygyno.2013.04.055
  18. Aksenova SP, Nudnov NV, Kreinina YuM. Magnetic resonance imaging of the vagina and pelvis in women undergoing anticancer treatment for cancer of the female genital organs. Medical Imaging. 2017;21(2):131-139. (In Russ.). https://doi.org/10.24835/1607-0763-2017-2-131-139
  19. Kinkel K, Hricak H, Lu Y, Tsuda K, Filly RA. US characterization of ovarian masses: a meta-analysis. Radiology. 2000;217(3):803-811.  https://doi.org/10.1148/radiology.217.3.r00dc20803
  20. Testa AC, Di Legge A, Virgilio B, Bonatti M, Manfredi R, Mirk P, Rufini V. Which imaging technique should we use in the follow up of gynaecological cancer? Best Pract Res Clin Obstet Gynaecol. 2014;28(5):769-791.  https://doi.org/10.1016/j.bpobgyn.2014.04.008
  21. Rosati A, Gueli Alletti S, Capozzi VA, Mirandola M, Vargiu V, Fedele C, Uccella S, Vascone C. Role of ultrasound in the detection of recurrent ovarian cancer: a review of the literature. Gland Surg. 2020;9(4):1092-1101. https://doi.org/10.21037/gs-20-357
  22. Ricke J, Sehouli J, Hach C, Hänninen EL, Lichtenegger W, Felix R. Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer. Eur Radiol. 2003;13(5):943-949.  https://doi.org/10.1007/s00330-002-1712-8
  23. Kim CK, Park BK, Choi JY, Kim BG, Han H. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT. J Comput Assist Tomogr. 2007;31(6):868-875.  https://doi.org/10.1097/rct.0b013e31803e8c45
  24. Olimov BP, Beregov MM, Kossov FA, Lapteva MG, Strel’tsova ON, Panichenko IV, Panov VO, Zhordania KI, Tyurin IE. Dynamic MRI with contrast enhancement in the differential diagnosis of adnexal tumors. Oncogynecology. 2019;(2):43-57. (In Russ.). https://doi.org/10.52313/22278710_2019_2_43
  25. Hameeduddin A, Sahdev A. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies. Cancer Imaging. 2015;15(1):3.  https://doi.org/10.1186/s40644-015-0037-1
  26. Fehniger J, Thomas S, Lengyel E, Liao C, Tenney M, Oto A, Yamada SD. A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies. Gynecol Oncol. 2016;142(1):169-175.  https://doi.org/10.1016/j.ygyno.2016.04.018
  27. Winfield JM, Wakefield JC, Dolling D, Hall M, Freeman S, Brenton JD, Lutchman-Singh K, Pace E, Priest AN, Quest RA, et al. Diffusion-weighted MRI in advanced epithelial ovarian cancer: apparent diffusion coefficient as a response marker. Radiology. 2019;293(2):374-383.  https://doi.org/10.1148/radiol.2019190545
  28. Low RN, Sebrechts CP, Barone RM, Muller W. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings — a feasibility study. AJR Am J Roentgenol. 2009;193(2):461-470.  https://doi.org/10.2214/AJR.08.1753
  29. Rubtsova NA, Novikova EG, Sychenkova IYu. Modern possibilities of magnetic resonance imaging in the diagnosis of ovarian cancer. Research and Practice in Medicine. 2017;4(1):40-48. (In Russ.). https://doi.org/10.17709/2409-2231-2017-4-1-5
  30. Arai K, Makino H, Morioka T, Yagi H, Minabe K, Takeyama S, Takashima T, Terayama N, Matsui O, Kadoya M. Enhancement of ascites on MRI following intravenous administration of Gd-DTPA. J Comput Assist Tomogr. 1993;17(4):617-622.  https://doi.org/10.1097/00004728-199307000-00019

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.